NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Nucleus RadioPharma

Nucleus RadioPharma

Private
Rochester, MinnesotaHealthcare & Life Scienceshttps://nucleusrad.com/

Last Round

Corporate Funding

Apr 20, 2026

Total Funding Raised

$112M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Nucleus RadioPharma is a biopharmaceutical company that operates as a contract development and manufacturing organization (CDMO) providing end-to-end supply chain and manufacturing services for targeted radiopharmaceutical therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Pharma Supply Chain, Precision Medicine, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

radiopharmaceuticalCDMOcontract development and manufacturing organizationradioligand therapyradioisotope supplyGMP manufacturingradiopharmasupply chain managementclinical supplytargeted therapyisotope logisticspharma outsourcingbiotech manufacturingdrug commercializationradioactive medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nucleus RadioPharma Comparables

Compare Nucleus RadioPharma with similar companies based on industry and business-model similarity.

Nucleus RadioPharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AtomVie Global Radiopharma Inc.
93%
SpectronRx
83%
Isotopia Molecular Imaging
80%

Nucleus RadioPharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingApr 20, 2026
Series A ExtensionJun 5, 2024
Series AOct 17, 2023
SeedOct 12, 2022

Key People

Founding team and executive leadership

Steve Hahn

Chief Executive Officer

Executive Team

Joe Warchol

Chief Financial Officer

Executive Team

Nucleus RadioPharma Investors

Notable investors and investment history

Nucleus RadioPharma investors
InvestorRounds
Granger ManagementSeries A
OrbiMedCorporate Funding
Eclipse VenturesSeed, Series A
Echo Investment CapitalSeries A
University of MissouriSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 20, 2026

    Monthly visitors increased 86% MoM, reaching 3.4K.

  • Apr 14, 2026

    Planned manufacturing facility in Spring House, Pennsylvania.

Nucleus RadioPharma Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nucleus RadioPharma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nucleus RadioPharma's valuation, stock price, and market status.

Firmographic Details

HeadquartersRochester, Minnesota
Employee Range54
Year Founded2022
Last FundingApr 20, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.